___
Pear Therapeutics rakes in $50M to develop additional digital therapeutics (MobiHealthNews):
“Boston- and San Francisco-based Pear Therapeutics, maker of a prescription digital therapeutic platform, announced today the closure of $50 million in Series B funding. The round was led by Singapore-based investment company Temasek, with participation from returning investors 5AM Ventures, Arboretum Ventures, and JAZZ Venture Partners, as well as new partners Novartis, EDBI, and the Bridge Builder’s Collaborative [Read more…] about Pear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health